Advanced Non-Small Cell Lung Cancer - Bayer 22615 HER2

Advanced Non-Small Cell Lung Cancer – Bayer 22615 HER2

Doctors are seeking adults living with non-small cell lung cancer to take part in a new clinical trial.

The purpose of this trial is to determine how well a new study drug works at treating non-small cell lung cancer compared to standard medical care.

There’s no cost to participate, and no health insurance is required to take part or receive study-related care.

Participants may receive a stipend for their time, up to $5,866. Participant caregivers may also receive compensation for their time.

You or a loved one may qualify for the clinical trial if:

At least 18 years old

Diagnosed with locally advanced or metastatic non-small cell lung cancer (NSCLC) with HER2-activating mutations
Additional criteria must also be met to qualify. Our study team is happy to help determine if you or a loved one may be eligible to take part.

View Study on ClinicalTrials.gov

Trial Interest Form

I am a...

First Name(Required)

Last Name(Required)

Location(Required)

Phone(Required)

Email(Required)

Gender

Conditions

Race

Contact Preference

How did you hear about us?

Other (Please specify)

This field is hidden when viewing the form

Trial (Origination Page)

This field is hidden when viewing the form

UTM Source

This field is hidden when viewing the form

UTM Medium

This field is hidden when viewing the form

UTM Campaign

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

Phone(Required)

Zip Code(Required)

What is the best way to contact you?(Required)

Comments(Required)

Please let us know what's on your mind. Have a question for us? Ask away.

This field is hidden when viewing the form

Origination Page

Advanced Non-Small Cell Lung Cancer – Bayer 22615 HER2